The DOI matches its Crossref record; 276 of the 276 references it cites were found in a registry or an index.
Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets
Open accessAbstract
Aberrant metabolism is a major hallmark of cancer. Abnormal cancer metabolism, such as aerobic glycolysis and increased anabolic pathways, has important roles in tumorigenesis, metastasis, drug resistance, and cancer stem cells. Well-known oncogenic signaling pathways, such as phosphoinositide 3-kinase (PI3K)/AKT, Myc, and Hippo pathway, mediate metabolic gene expression and increase metabolic enzyme activities. Vice versa, deregulated metabolic pathways contribute to defects in cellular signal transduction pathways, which in turn provide energy, building blocks, and redox potentials for unrestrained cancer cell proliferation. Studies and clinical trials are being performed that focus on the inhibition of metabolic enzymes by small molecules or dietary interventions (e.g., fasting, calorie restriction, and intermittent fasting). Similar to genetic heterogeneity, the metabolic phenotypes of cancers are highly heterogeneous. This heterogeneity results from diverse cues in the tumor microenvironment and genetic mutations. Hence, overcoming metabolic plasticity is an important goal of modern cancer therapeutics. This review highlights recent findings on the metabolic phenotypes of cancer and elucidates the interactions between signal transduction pathways and metabolic pathways. We also provide novel rationales for designing the next-generation cancer metabolism drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–276 of 276
Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions
Vernieri, C., Casola, S., Foiani, M., Pietrantonio, F., de Braud, F., & Longo, V. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0615 · Cited by 202
Kim, J., Yu, L., Chen, W., Xu, Y., Wu, M., Todorova, D., Tang, Q., Feng, B., Jiang, L., He, J., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2018.12.012 · Cited by 202
Galloflavin (CAS 568‐80‐9): A Novel Inhibitor of Lactate Dehydrogenase
Manerba, M., Vettraino, M., Fiume, L., Di Stefano, G., Sartini, A., Giacomini, E., Buonfiglio, R., Roberti, M., & Recanatini, M. (2012) · ChemMedChem · doi:10.1002/cmdc.201100471 · Cited by 198
Kim, C., Lee, S.-G., Yang, W. M., Arfuso, F., Um, J.-Y., Kumar, A. P., Bian, J., Sethi, G., & Ahn, K. S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.038 · Cited by 195
In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells
Jiang, P., Mukthavaram, R., Chao, Y., Nomura, N., Bharati, I. S., Fogal, V, Pastorino, S., Teng, D., Cong, X., Pingle, S. C., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.431 · Cited by 194
The Role of Hippo Pathway in Cancer Stem Cell Biology.
Park, J. H., Shin, J. E., & Park, H. W. (2018) · PubMed · doi:10.14348/molcells.2018.2242 · Cited by 193
Self-citationROS-Mediated p53 Induction of Lpin1 Regulates Fatty Acid Oxidation in Response to Nutritional Stress
Assaily, W., Rubinger, D. A., Wheaton, K., Lin, Y., Ma, W., Xuan, W., Brown-Endres, L., Tsuchihara, K., Mak, T. W., & Benchimol, S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.038 · Cited by 192
HIF1/2α mediates hypoxia-induced LDHA expression in human pancreatic cancer cells
Cui, X.-G., Han, Z.-T., He, S.-H., Wu, X.-D., Chen, T.-R., Shao, C.-H., Chen, D.-L., Su, N., Chen, Y.-M., Wang, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15266 · Cited by 191
Lnc RNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism
Zheng, X., Han, H., Liu, G., Ma, Y., Pan, R., Sang, L., Li, R., Yang, L., Marks, J. R., Wang, W., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201797609 · Cited by 191
Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathway
West, M. J., Stoneley, M., & Willis, A. E. (1998) · Oncogene · doi:10.1038/sj.onc.1201990 · Cited by 183
Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate
Korangath, P., Teo, W. W., Sadik, H., Han, L., Mori, N., Huijts, C. M., Wildes, F., Bharti, S., Zhang, Z., Santa-Maria, C. A., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1200 · Cited by 182
Kato, Y., Lambert, C. A., Colige, A. C., Mineur, P., Noël, A., Frankenne, F., Foidart, J.-M., Baba, M., Hata, R.-I., Miyazaki, K., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411313200 · Cited by 182
AMP-activated protein kinase promotes human prostate cancer cell growth and survival
Park, H. U., Suy, S., Danner, M., Dailey, V., Zhang, Y., Li, H., Hyduke, D. R., Collins, B. T., Gagnon, G., Kallakury, B., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0631 · Cited by 176
Self-citationEGFR-Pak signaling selectively regulates glutamine deprivation-induced macropinocytosis
Lee, S.-W., Zhang, Y., Jung, M., Cruz, N., Alas, B., & Commisso, C. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.05.043 · Cited by 172
Cannell, I. G., Kong, Y. W., Johnston, S. J., Chen, M. L., Collins, H. M., Dobbyn, H. C., Elia, A., Kress, T. R., Dickens, M., Clemens, M. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910015107 · Cited by 172
Role of Bach1 and Nrf2 in up‐regulation of the heme oxygenase‐1 gene by cobalt protoporphyrin
Shan, Y., Lambrecht, R. W., Donohue, S. E., Bonkovsky, H. L., Shan, Y., Lambrecht, R. W., Donohue, S. E., & Bonkovsky, H. L. (2006) · The FASEB Journal · doi:10.1096/fj.06-6346fje · Cited by 169
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma
Cosset, É., Ilmjärv, S., Dutoit, V., Elliott, K., von Schalscha, T., Camargo, M. F., Reiss, A., Moroishi, T., Seguin, L., Gomez, G., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.10.016 · Cited by 166
Mechanisms of lapatinib resistance in HER2-driven breast cancer
D’Amato, V., Raimondo, L., Formisano, L., Giuliano, M., De Placido, S., Rosa, R., & Bianco, R. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.08.001 · Cited by 164
c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry
Morrish, F., Isern, N., Sadilek, M., Jeffrey, M., & Hockenbery, D. M. (2009) · Oncogene · doi:10.1038/onc.2009.112 · Cited by 164
Ren, P., Yue, M., Xiao, D., Xiu, R., Gan, L., Liu, H., & Qing, G. (2014) · The Journal of Pathology · doi:10.1002/path.4429 · Cited by 163
Regulation of MYC gene expression by aberrant Wnt/β-catenin signaling in colorectal cancer
Rennoll, S. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i4.290 · Cited by 162
Beloueche‐Babari, M., Wantuch, S., Casals, T., Koniordou, M., Parkes, H. G., Arunan, V., Chung, Y., Eykyn, T. R., Smith, P. D., & Leach, M. O. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2686 · Cited by 162
Morrish, F. M., Noonan, J., Olsen, C. P., Gafken, P. R., Fitzgibbon, M., Kelleher, J. K., VanGilst, M., & Hockenbery, D. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.141606 · Cited by 161
Identifying strategies to target the metabolic flexibility of tumours
Méndez‐Lucas, A., Lin, W., Driscoll, P. C., Legrave, N. M., Novellasdemunt, L., Xie, C., Charles, M. D., Wilson, Z., Jones, N. P., Rayport, S., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0195-8 · Cited by 161
Li, Y.-J. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i14.2117 · Cited by 160
Anticancer Activity of Metformin: A Systematic Review of the Literature
Aljofan, M., & Riethmacher, D. (2019) · Future Science OA · doi:10.2144/fsoa-2019-0053 · Cited by 160
Park, Y., Sohn, B. H., Johnson, R. L., Kang, M., Kim, S. B., Shim, J., Mangala, L. S., Kim, J. H., Yoo, J. E., Rodriguez‐Aguayo, C., et al. (2015) · Hepatology · doi:10.1002/hep.28223 · Cited by 159
Alwarawrah, Y., Hughes, P. F., Loiselle, D. R., Carlson, D. A., Darr, D. B., Jordan, J. L., Xiong, J., Hunter, L., Dubois, L. G., Thompson, J. W., et al. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.04.011 · Cited by 159
mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer
Sodi, V. L., Khaku, S., Krutilina, R. I., Schwab, L. P., Vocadlo, D. J., Seagroves, T. N., & Reginato, M. J. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0536 · Cited by 156
The B55α Subunit of PP2A Drives a p53-Dependent Metabolic Adaptation to Glutamine Deprivation
Reid, M. A., Wang, W.-I., Rosales, K. R., Welliver, M. X., Pan, M., & Kong, M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.008 · Cited by 154
Ng, T. L., Leprivier, G., Robertson, M. D., Chow, C., Martin, M. J., Laderoute, K. R., Davicioni, E., Triche, T. J., & Sorensen, P. H. B. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.119 · Cited by 150
Seguin, F., Carvalho, M. A., Bastos, D., Agostini, M., Zecchin, K. G., Alvarez-Flores, M. P., Chudzinski-Tavassi, A., Coletta, R. D., & Graner, E. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.355 · Cited by 148
Zhang, C., Liu, J., Huang, G., Zhao, Y., Yue, X., Wu, H., Li, J., Zhu, J., Shen, Z., Haffty, B. G., et al. (2016) · Genes & Development · doi:10.1101/gad.283283.116 · Cited by 145
Frigo, D. E., Howe, M. K., Wittmann, B. M., Brunner, A. M., Cushman, I., Wang, Q., Brown, M. A., Means, A. R., & McDonnell, D. P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2581 · Cited by 144
Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer
Kim, S., Kim, D. H., Jung, W.-H., & Koo, J. S. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0398 · Cited by 138
FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of ArfPreprint
Bouchard, C., Lee, S., Paulus-Hock, V., Loddenkemper, C., Eilers, M., & Schmitt, C. A. (2007) · Genes & Development · doi:10.1101/gad.453107 · Cited by 136
ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer
Deblois, G., Smith, H. W., Tam, I. S., Gravel, S., Caron, M., Savage, P., Labbé, D. P., Bégin, L. R., Tremblay, M. L., Park, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12156 · Cited by 134
FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function
Jensen, K. S., Binderup, T., Jensen, K. T., Therkelsen, I., Borup, R., Nilsson, E., Multhaupt, H. A. B., Bouchard, C., Quistorff, B., Kjær, A., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.323 · Cited by 131
Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer
Dasgupta, B., & Chhipa, R. R. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.11.007 · Cited by 131
Komurov, K., Tseng, J., Muller, M., Seviour, E. G., Moss, T. J., Yang, L., Nagrath, D., & Ram, P. T. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.25 · Cited by 130
Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death
Catanzaro, D., Gaude, E., Orso, G., Giordano, C., Guzzo, G., Rasola, A., Ragazzi, E., Caparrotta, L., Frezza, C., & Montopoli, M. (2015) · Oncotarget · doi:10.18632/oncotarget.4945 · Cited by 129
Kim, E.-Y., Chung, T., Han, C. W., Park, M.-J., Park, K. H., Jang, S. B., & Ha, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-40617-3 · Cited by 129
Metabolic Regulation of Redox Balance in Cancer
Purohit, V., Simeone, D. M., & Lyssiotis, C. A. (2019) · Cancers · doi:10.3390/cancers11070955 · Cited by 126
Regulatory Role of Glycogen Synthase Kinase 3 for Transcriptional Activity of ADD1/SREBP1c
Kim, K. H., Song, M. J., Yoo, E. J., Choe, S. S., Park, S. D., & Kim, J. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405522200 · Cited by 122
Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth
Cox, A. G., Tsomides, A., Yimlamai, D., Hwang, K. L., Miesfeld, J. B., Galli, G. G., Fowl, B. H., Fort, M. W., Kimberly, Y., Sullivan, M. R., et al. (2018) · The EMBO Journal · doi:10.15252/embj.2018100294 · Cited by 120
p53 regulates glucose metabolism by miR-34a
Kim, H.-R., Roe, J., Lee, J., Cho, E., & Youn, H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.043 · Cited by 116
Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer
Wangpaichitr, M., Wu, C., Li, Y. Y., Nguyen, D. J. M., Kandemir, H., Shah, S. S., Chen, S., Feun, L. G., Prince, J. S., Kuo, M. T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17568 · Cited by 116
The regulation of cancer cell death and metabolism by extracellular matrix attachment
Buchheit, C. L., Rayavarapu, R. R., & Schafer, Z. T. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.04.007 · Cited by 115
Saha, A., Connelly, S., Jiang, J., Zhuang, S., Amador, D., Phan, T., Pilz, R. B., & Boss, G. R. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.028 · Cited by 113
Edwards, D. N., Ngwa, V. M., Wang, S., Shiuan, E. F., Brantley‐Sieders, D. M., Kim, L. C., Reynolds, A. B., & Chen, J. (2017) · Science Signaling · doi:10.1126/scisignal.aan4667 · Cited by 111
Warrier, S. R., Bhuvanalakshmi, G., Arfuso, F., Rajan, G. P., Millward, M., & Dharmarajan, A. (2014) · Cancer Gene Therapy · doi:10.1038/cgt.2014.42 · Cited by 108
The impact of oncogenic RAS on redox balance and implications for cancer development
Lim, J. K. M., & Leprivier, G. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2192-y · Cited by 108
Tumor induction by the c-Myc target genes rcl and lactate dehydrogenase A.
Lewis, B. C., Prescott, J. E., Campbell, S. E., Shim, H., Orlowski, R. Z., & Dang, C. V. (2000) · PubMed · Cited by 104
Dai, X., Wang, L., Deivasigamni, A., Looi, C. Y., Karthikeyan, C., Trivedi, P., Chinnathambi, A., Alharbi, S. A., Arfuso, F., Dharmarajan, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14606 · Cited by 104
Glutaminolysis drives membrane trafficking to promote invasiveness of breast cancer cells
Dornier, E., Rabas, N., Mitchell, L. E., Novo, D., Dhayade, S., Marco, S., Mackay, G., Sumpton, D. P., Pallarès-Masmitjà, M., Nixon, C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02101-2 · Cited by 103
Glutamine‐utilizing transaminases are a metabolic vulnerability of TAZ/YAP‐activated cancer cells
Yang, C., Stampouloglou, E., Kingston, N. M., Zhang, L., Monti, S., & Varelas, X. (2018) · EMBO Reports · doi:10.15252/embr.201643577 · Cited by 102
Sanchez-Macedo, N., Feng, J., Faubert, B., Chang, N., Elia, A., Rushing, E. J., Tsuchihara, K., Bungard, D., Berger, S. L., Jones, R. G., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.168 · Cited by 98
Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases
Liu, T., Zhou, Y., Ko, K. S., & Yang, H. (2015) · Mediators of Inflammation · doi:10.1155/2015/276850 · Cited by 96
AberrantKeap1methylation in breast cancer and association with clinicopathological features
Barbano, R., Muscarella, L. A., Pasculli, B., Valori, V. M., Fontana, A., Coco, M., la Torre, A., Balsamo, T., Poeta, M. L., Marangi, G. F., et al. (2012) · Epigenetics · doi:10.4161/epi.23319 · Cited by 94
Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletion
Juvekar, A., Hu, H., Yadegarynia, S., Lyssiotis, C. A., Ullas, S., Lien, E. C., Bellinger, G., Son, J., Hok, R. C., Seth, P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522223113 · Cited by 93
CXCR4 as biomarker for radioresistant cancer stem cells
Trautmann, F., Cojoc, M., Kurth, I., Mélin, N., Bouchez, L. C., Dubrovska, A., & Peitzsch, C. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.906766 · Cited by 90
Geranylgeranylation signals to the Hippo pathway for breast cancer cell proliferation and migration
Mi, W., Lin, Q., Childress, C., Sudol, M., Robishaw, J. D., Berlot, C. H., Shabahang, M. M., & Yang, W. (2014) · Oncogene · doi:10.1038/onc.2014.251 · Cited by 88
Emerging evidence for targeting mitochondrial metabolic dysfunction in cancer therapy
Zhu, Y., Dean, A. E., Horikoshi, N., Heer, C. D., Spitz, D. R., & Gius, D. R. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120844 · Cited by 85
Regulation of the Hippo pathway in cancer biology
Moon, S., Park, S. Y., & Park, H. W. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2804-1 · Cited by 83
Self-citationLiu, Y., He, Y., Jin, A., Tikunov, A. P., Zhou, L., Tollini, L. A., Leslie, P., Kim, T.-H., Li, L. O., Coleman, R. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315605111 · Cited by 80
Tedeschi, P. M., Vázquez, A., Kerrigan, J. E., & Bertino, J. R. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0117 · Cited by 77
Li, S., Oh, Y.-T., Yue, P., Khuri, F. R., & Sun, S.-Y. (2015) · Oncogene · doi:10.1038/onc.2015.123 · Cited by 76
YAP and TAZ are dispensable for physiological and malignant haematopoiesis
Donato, E., Biagioni, F., Bisso, A., Cagánová, M., Amati, B. B., & Campaner, S. (2018) · Leukemia · doi:10.1038/s41375-018-0111-3 · Cited by 63
IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth
Venmar, K. T., Kimmel, D. W., Cliffel, D. E., & Fingleton, B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.02.020 · Cited by 60
O -GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity
Kim, E., Kang, J. G., Kang, M. J., Park, J. H., Kim, Y. J., Kweon, T. H., Lee, H., Jho, E., Lee, Y., Kim, S.-I., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913469117 · Cited by 58
Self-citationFOXC2 positively regulates YAP signaling and promotes the glycolysis of nasopharyngeal carcinoma
Song, L., Tang, H., Liao, W., Luo, X., Li, Y., Chen, T., & Zhang, X. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.04.019 · Cited by 54
Nakakuki, M., Kawano, H., Notsu, T., Imada, K., Mizuguchi, K., & Shimano, H. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu019 · Cited by 35
Dong, Q., Giorgianni, F., Beranová-Giorgianni, Š., Deng, X., O’Meally, R. N., Bridges, D., Park, E. A., Cole, R. N., Elam, M. B., & Raghow, R. (2015) · Bioscience Reports · doi:10.1042/bsr20150234 · Cited by 32
The PGC-1/ERR network and its role in precision oncology
Vitto, H. D., Bode, A. M., & Dong, Z. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0081-6 · Cited by 32
L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer
(1986) · Lung Cancer · doi:10.1016/s0169-5002(86)80709-7 · Cited by 28
Links between Serine Biosynthesis Pathway and Epigenetics in Cancer Metabolism
Kim, H., & Park, Y. J. (2018) · Clinical Nutrition Research · doi:10.7762/cnr.2018.7.3.153 · Cited by 26
Cited by
Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation
Schiliro, C., & Firestein, B. L. (2021) · Cells · doi:10.3390/cells10051056 · Cited by 615
The Bioavailability of Drugs—The Current State of Knowledge
Stielow, M., Witczyńska, A., Kubryń, N., Fijałkowski, Ł., Nowaczyk, J., & Nowaczyk, A. (2023) · Molecules · doi:10.3390/molecules28248038 · Cited by 391
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer
Labrie, M., Brugge, J. S., Mills, G. B., & Zervantonakis, I. K. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00454-5 · Cited by 369
Zhong, X., He, X., Wang, Y., Hu, Z., Huang, H., Zhao, S., Wei, P., & Li, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01358-5 · Cited by 329
Brown-fat-mediated tumour suppression by cold-altered global metabolism
Seki, T., Yang, Y., Sun, X., Lim, S., Xie, S., Guo, Z., Xiong, W., Kuroda, M., Sakaue, H., Hosaka, K., et al. (2022) · Nature · doi:10.1038/s41586-022-05030-3 · Cited by 263
Metadata
- Authors
- Park, J. H., Pyun, W. Y., & Park, H. W.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-10-16
- Volume
- 9
- Issue
- 10
- Pages
- 2308
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3093872008
- Cited by
- 548
- References
- 276
- FWCI
- 20.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.